The information was shared in a written reply in reply to questions raised by MP MS Swati Maliwal and MP Shri Rajeev Shukla. The National Action Plan on Antimicrobial Resistance (NAP-AMR) 2.0 is India's strategic 5-year blueprint (2025–2029) launched by MoHFW to combat drug resistance through optimized stewardship, multi-sectoral coordination, and robust surveillance.
Jadhav pointed out that the action plan promotes implementation of antimicrobial stewardship programmes in healthcare settings, aligns with surveillance networks, and prioritises behaviour change communication and public awareness campaigns targeting all stakeholders, including healthcare professionals, veterinarians, farmers, and the community, to promote rational and judicious use of antimicrobials.
The MPs sought to know whether the Government has taken note of the growing challenge of antimicrobial resistance due to inappropriate and non-prescriptive use of antibiotics resulting in their misuse and overuse; the steps taken to monitor antibiotic consumption and prevent the sale of antibiotics without proper prescription.
They also asked whether a national strategy has been implemented to address antimicrobial resistance and strengthen surveillance mechanisms to promote responsible antibiotic use; and the measures taken to promote awareness and strengthen antimicrobial stewardship among healthcare professionals and the general public regarding the rational use of antibiotics.
Responding to the questions, the Minister informed that the government is aware of the growing challenge of Antimicrobial Resistance (AMR) in the country. To address this public health concern, the government has taken a number of strategic and coordinated measures across sectors. The Government of India, through the Central Drugs Standard Control Organization (CDSCO), regulates the safety, efficacy, and quality of drugs under the provisions of the Drugs & Cosmetics Act, 1940 & its rules.
Moreover, the sale and distribution of drugs is regulated by State Licensing Authorities under Drugs Rules 1945. Further, the State Drugs Controllers/other stakeholders have been sensitized about concerns regarding sale of prescription drugs by retail without prescription of Registered Medical Practitioners. Various Notices/Advisories/Letters have been issued to State Drugs Controllers and other stakeholders for strict compliance of the requirements of Drugs and Cosmetics Act and Rules, added the minister.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.